55292-820-01 : NDC 2026 Code

55292-820-01 : Sutimlimab-jome ( Enjaymo )

Additionally :

You can get information about “55292-820-01” NDC code in 55292-820-01 in HTML format

HTML | 55292-820-01 in TXT (Plain Text) format

TXT | 55292-820-01 in PDF (Portable Document Format)

PDF | 55292-820-01 in XML format

XML formats.

NDC Code : 55292-820-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "55292-820-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (55292-820-01)  / 22 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "55292-0820-01",
    "ProductNDC": "55292-820",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Enjaymo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Sutimlimab-jome",
    "DosageFormName": "INJECTION, SOLUTION, CONCENTRATE",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20220204",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761164",
    "LabelerName": "Recordati Rare Diseases, Inc.",
    "SubstanceName": "SUTIMLIMAB",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Classical Complement Pathway Inhibitor [EPC], Classical Complement Pathway Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-06-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250625",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}